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SUMMARY
In this work we present a systematic effort to summarize current biological pathway knowledge 
concerning Rheumatoid Arthritis (RA). We are constructing a detailed molecular map based on 
exhaustive literature scanning, strict curation criteria, re-evaluation of previously published 
attempts and most importantly experts’ advice. The RA map will be web-published in the coming 
months in the form of an interactive map, using the MINERVA platform, allowing for easy access, 
navigation and search of all molecular pathways implicated in RA, serving thus, as an on line 
knowledgebase for the disease. Moreover the map could be used as a template for Omics data 
visualization offering a first insight about the pathways affected in different experimental datasets. 
The second goal of the project is a dynamical study focused on synovial fibroblasts’ behavior 
under different initial conditions specific to RA, as recent studies have shown that synovial 
fibroblasts play a crucial role in driving the persistent, destructive characteristics of the disease. 
Leaning on the RA knowledgebase and using the web platform Cell Collective, we are currently 
building a Boolean large scale dynamical model for the study of RA fibroblasts’ activation.
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Protein-protein interactions are a major driving force behind most biological processes. They 
play a pivotal role in intra- and extra-cellular functions, and especially in the propagation of 
signals and cellular regulation. Signal transduction is a fundamental process for the 
communication of the cell with its environment, comprising several interacting receptors, 
proteins, enzymes, second messengers and transcription factors. Disruption and 
dysregulation of these complex molecular and signaling networks can lead to disease. 
Therefore, the mapping and accurate representation of pathways implicated is a primary but 
essential step for elucidating the mechanisms underlying disease pathogenesis.
The release of various molecular maps dealing with obesity [1], gastrin and cholecystokinin 
receptors signaling [2], FceRI receptor signaling in allergy [3], MAPKs [4], mTOR 
signaling [5] to name a few, corroborates the fact that pathway assembly in the form of 
network is gaining ground in systems biology. As more scientists invest time and effort to 
construct large molecular networks, there is an increasing need for practical guidelines and a 
standardized framework. Toward this direction, initiatives have emerge, such as The Cancer 
Cell Map Initiative [6], the Atlas of Cancer Signaling Networks (http://acsn.curie.fr) 
concerning cancer, and the Disease Maps Project (http://disease-maps.org), an open, large-
scale community effort that consists of a network of groups working together for developing 
best practices, standards and tools in order to better represent disease mechanisms.
However, as all living systems are dynamic in nature, static representations of molecular 
networks can provide useful but relatively limited understanding. A dynamical study can 
reveal information about the system’s behavior under different conditions by in silico 
simulations, perturbations, hypotheses testing and predictions. Quantitative kinetic 
modelling approaches using differential or stochastic equations can provide a detailed 
analysis of a network’s dynamics, but the large number of parameters required make them 
less appropriate for large scale signaling networks. In order to address the lack of kinetic 
data, discrete logical modelling can be used as an alternative way to study the system’s 
qualitative dynamic behavior [7, 8].
In this work we present a systematic effort to summarize current biological pathway 
knowledge concerning Rheumatoid Arthritis (RA), a multifactorial autoimmune disease that 
causes chronic inflammation of the synovial joints with an etiology that still remains 
unclear. With the use of the software CellDesigner [9], we are constructing a detailed 
molecular map based on exhaustive literature scanning, strict curation criteria, re-evaluation 
of previously published attempts [10] and most importantly experts’ advice (Figure 1).
In 2010 Wu et al. published a detailed molecular map concerning rheumatoid arthritis using 
the software CellDesigner. We decided to use this map as a basis, and expand. The map has 
been updated with information published after 2010 by exhaustive manual curation and the 
help of data mining tools. Only experimentally validated interactions in at least two peer 
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reviewed scientific publications are kept. Due to the fact that the initial map was based on 
high throughput gene expression data from 28 studies and interactions inferred from KEGG 
database, all nodes and interactions are re-evaluated carefully in an effort to limit false 
positives. When validation with small scale experiments is not possible, we keep nodes that 
appear in at least two different high throughput studies. Detailed annotation including 
PubMED IDs and HUGO names is also added in the MIRIAM section of the CellDesigner 
file. As far as context representation and overall structure of the map, expert’s advice has 
been taken into account along with an effort to comply with SBGN standards.
The RA map will be web-published in the coming months (a full length manuscript is under 
preparation) in the form of an interactive map, using the platform MINERVA [11], allowing 
for easy access, navigation and search of all molecular pathways implicated in RA, serving 
thus, as an on line knowledge base for the disease. The user will have access to all literature 
used, with detailed annotations for every component and reaction, including PubMed IDs, 
and a list of identifiers such as Uniprot, EntrezGene, Ensembl, HGNC and RefSeq. As the 
map is constructed using information from various experimental studies, the user will also 
be able to opt for visualization of data with specific cell origin, highlighting cell-specific 
sub-networks within the global one. Moreover, the user will have the possibility to spot all 
known drug targets, and the corresponding drugs up to date for RA. Detailed view of an 
element will allow the search for drugs, chemicals and miRNAs targeting this particular 
element. Additionally, user-provided omic datasets could be displayed as overlay, giving a 
first estimation of affected pathways and components. Lastly, the map will provide feedback 
about the unmapped molecules from the dataset, allowing for better understanding of the 
experimental results and for further development of the map’s contents. We have used public 
datasets from proteomic and transcriptomic studies [12–14] to demonstrate how the map can 
be used as a template for separate or simultaneous visualization of different experimental 
results. The map will also be used for the mapping of in-house data concerning the 
transcriptome analysis of ten individuals that developed RA (measurements before the onset 
of the disease and early after) (Teixeira et al., under preparation).
The RA map so far includes information derived from more than 100 scientific papers. It has 
six distinct compartments, namely extracellular space (with extracellular proteins), plasma 
membrane (with membrane receptors and ligand proteins), cytoplasm (with proteins, 
miRNAs, small molecules and the sub-compartments of mitochondrion, Golgi apparatus and 
endoplasmic reticulum), nucleus (with genes, RNAs and transcription factors), a 
compartment for the secreted molecules and a phenotype compartment including more than 
ten cellular fates. It comprises more than 400 components and a total of 324 reactions. Each 
component and reaction in the map is referenced with at least two PubMed IDs or database 
identifiers if inferred from a specific database.
Topological analysis of the RA map using the software Cytoscape [15] and relevant plugins 
reveals unconnected or loosely connected parts that reflect our fragmented knowledge about 
physical and/or genetic interactions, posing thus obstacles in the subsequent derivation of a 
reliable dynamical model. To improve connectivity we use dedicated PPI databases (through 
http://www.imexconsortium.org), pathway databases (e.g. KEGG, SIGNOR or 
REACTOME) and the commercial software Ingenuity Pathway Analysis (IPA, http://
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www.ingenuity.com) in order to investigate potential co-players of the proteins of interest. 
For the time being, we do not make use of simulated/computationally inferred interactions or 
interactions inferred from other species (i.e. mice), restricting our search to experimentally 
validated data of human origin.
Characteristic features of RA include synovial inflammation that can lead to bone erosion 
and permanent deformity. It is broadly recognized that in RA, synovial inflammation results 
from complex interactions between haematopoietic and stromal cells. Recent studies have 
shown that RA synovial fibroblasts play a crucial role in driving the persistent, destructive 
characteristics of the disease [16].
The second scope of the project is to model synovial fibroblasts behavior under different 
initial conditions specific to RA, in order to see if we could influence the cellular fate (e.g. 
enhancing an apoptotic phenotype) or understand what could lead to patient’s resistance to a 
certain drug and how to overcome it (e.g. presence of rescue pathways, complex feedback 
mechanisms).
In general, pathway representation and modelling can be seen as two separate tasks with 
different primary objectives. The first is to draw an accurate, comprehensive diagram 
depicting current biological knowledge while the second is to study the emergent behavior 
of the system under different conditions. However, a detailed, fully annotated molecular map 
works as an excellent scaffold for the building of a regulatory graph and the subsequent 
derivation of the logical model. This process, that involves many iterations, obliges one to 
look meticulously into the mapped pathways, spotting potentially problematic or ambiguous 
aspects of the map. Model simulations can also reveal inconsistencies concerning the global 
behavior, advocating the necessity for further revisions and refinements. Leaning on the RA 
knowledge base and using the web platform Cell Collective [17], we are currently building a 
Boolean dynamical model for the study of RA fibroblasts’ activation. The model is based on 
a previously published, more generic model on fibroblasts [18] that is being modified 
accordingly in order to be RA specific.
In Boolean formalism, nodes represent regulatory components (proteins, complexes, 
transcription factors, etc.) and arcs represent their interactions. Each regulatory component is 
associated with a Boolean variable (taking the values 0 or 1) denoting its qualitative 
concentration or level of activity (0 for absent or inactive, 1 for present or active). The future 
state of each node depends on the states of its upstream regulators and is defined by a 
Boolean function, expressed in the form of a rule using the logical operators AND, OR and 
NOT.
The tuning of the model includes testing against published data and appropriate 
modifications of logical rules and/or addition/deletion of interactions/components until it is 
able to reproduce well established input-output relations (global behavior). This process will 
inevitably lead back to the re-evaluation of the molecular map and further discussions with 
experts until all issues are resolved in a biologically sound way. The model will then be used 
to systematically test different initial conditions and stimuli (presence or absence of different 
cytokines and growth factors, and their combinations). The aim is to predict the system’s 
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response to single or combined perturbations, and identify novel targets for pharmacological 
intervention.
The Boolean model will be made publicly available in Cell Collective for further 
contributions, simulations, and analyses by the research community, hopefully within 2018. 
The web based platform Cell Collective allows real time simulations without the need for 
software installation making the model more accessible to a wider audience. Moreover, the 
platform supports annotation, so the user can have simultaneous access to the model 
description, the rules and the literature used for the rules’ inference.
Lastly, the resulting logical model for RA fibroblasts could be further analyzed with the 
software GINsim [19] and also serve as a template for the derivation of a continuous model 
using the software MaBoSS [20] allowing the computation of phenotype probabilities.
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Figure 1. Data integration workflow
The building of a logical model is an iterative multistep process. The assembly of a 
molecular map comprising biological pathways of interest and integrating information from 
literature and public databases could serve as the first step. Experts’ feedback assures the 
quality of the map and the accuracy of the knowledge represented, along with strict curation 
criteria and standards for the graphical representation. Web publication facilitates 
community feedback and transforms the map in a powerful data analysis and visualization 
tool. The network can be further exploited using graph analysis tools to identify important 
nodes and pathways, or it can serve as a scaffold for dynamical models allowing simulations. 
Interesting predictions can then be experimentally tested, contributing to the validation and 
refinement of the map. Regular revisions are also necessary to ensure the incorporation of 
novel data (Figure adapted from Niarakis et al., 2014 [3]).
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